Oral Decitabine and Cedazuridine (ASTX727) Granted Orphan Drug Designation (ODD) by the European Commission for the Treatment of Acute Myeloid Leukemia (AML) January 6, 2022 by Businesswire [#item_full_content] Related Spread the word